Table 6.
Parameters | 3D-CRT | IMRT | VMAT | 3D-CRT vs IMRT | 3D-CRT vs VMAT | 3D-CRT vs VMAT | ||||||
Without supraclavicular lymph node | With supraclavicular lymph node | Without supraclavicular lymph node | With supraclavicular lymph node | Without supraclavicular lymph node | With supraclavicular lymph node | Without supraclavicular lymph node | With supraclavicular lymph node | Without supraclavicular lymph node | With supraclavicular lymph node | Without supraclavicular lymph node | With supraclavicular lymph node | |
Spinal cord | ||||||||||||
Dmax (Gy) | 0.519±0.19 | 28.800±7.72 | 1.074±0.88 | 25.318±6.49 | 7.543±2.72 | 26.760±2.89 | 0.074 | 0.507 | 0.0001 (<0.001) | 0.639 | 0.0001 (<0.001) | 0.62 |
Oesophagus | ||||||||||||
Dmax (Gy) | 0.911±0.29 | 36.660±20.37 | 3.662±3.50 | 39.928±12.15 | 10.521±2.35 | 41.108±12.94 | 0.058 | 0.62 | 0.004 (<0.01) | 0.612 | <0.0001 (<0.0001) | 0.360 |
3D, three dimensional; CRT, conformal radiotherapy; D95, the dose distributed in ≥95% of the PTV; Dmean, mean dose; IMRT, intensity-modulated radiotherapy; PTV, planning target volume; VMAT, volumetric modulated arc therapy.